178 related articles for article (PubMed ID: 37599093)
21. Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Nahed BV; Redjal N; Brat DJ; Chi AS; Oh K; Batchelor TT; Ryken TC; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):609-30. PubMed ID: 26530264
[TBL] [Abstract][Full Text] [Related]
22. Compromised health-related quality of life in patients with low-grade glioma.
Aaronson NK; Taphoorn MJ; Heimans JJ; Postma TJ; Gundy CM; Beute GN; Slotman BJ; Klein M
J Clin Oncol; 2011 Nov; 29(33):4430-5. PubMed ID: 22010018
[TBL] [Abstract][Full Text] [Related]
23. Quality of life measures in glioma patients with different grades: A preliminary study.
Mahalakshmi P; Vanisree AJ
Indian J Cancer; 2015; 52(4):580-5. PubMed ID: 26960484
[TBL] [Abstract][Full Text] [Related]
24. Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs).
Nwachukwu CR; Youland RS; Chioreso C; Wetjen N; NageswaraRao A; Keating G; Laack NN
J Neurooncol; 2015 Feb; 121(3):599-607. PubMed ID: 25467557
[TBL] [Abstract][Full Text] [Related]
25. Imaging signatures of meningioma and low-grade glioma: a diffusion tensor, magnetization transfer and quantitative longitudinal relaxation time MRI study.
Piper RJ; Mikhael S; Wardlaw JM; Laidlaw DH; Whittle IR; Bastin ME
Magn Reson Imaging; 2016 May; 34(4):596-602. PubMed ID: 26708035
[TBL] [Abstract][Full Text] [Related]
26. Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma.
Park DY; Tom MC; Wei W; Tewari S; Ahluwalia MS; Yu JS; Chao ST; Suh JH; Peereboom D; Stevens GHJ; Barnett GH; Angelov L; Mohammadi AM; Hogan T; Kissel C; Lapin B; Schuermeyer I; Parsons MW; Naugle R; Murphy ES
J Neurooncol; 2022 Feb; 156(3):499-507. PubMed ID: 35064450
[TBL] [Abstract][Full Text] [Related]
27. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
Tom MC; Park DYJ; Yang K; Leyrer CM; Wei W; Jia X; Varra V; Yu JS; Chao ST; Balagamwala EH; Suh JH; Vogelbaum MA; Barnett GH; Prayson RA; Stevens GHJ; Peereboom DM; Ahluwalia MS; Murphy ES
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1106-1112. PubMed ID: 31461674
[TBL] [Abstract][Full Text] [Related]
28. Extent of Resection and Long-Term Survival of Pineal Region Tumors in Helsinki Neurosurgery.
Choque-Velasquez J; Resendiz-Nieves J; Jahromi BR; Colasanti R; Raj R; Vehviläinen J; Tynninen O; Collan J; Niemelä M; Hernesniemi J
World Neurosurg; 2019 Nov; 131():e379-e391. PubMed ID: 31369883
[TBL] [Abstract][Full Text] [Related]
29. Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors.
Kemerdere R; Akgun MY; Toklu S; Aydin S; Orhan B; Inal BB; Korkmaz TS; Aktas B; Kacira T; Tanriverdi T
Turk Neurosurg; 2021; 31(3):399-403. PubMed ID: 33759165
[TBL] [Abstract][Full Text] [Related]
30. The effect of pregnancy on survival in a low-grade glioma cohort.
Rønning PA; Helseth E; Meling TR; Johannesen TB
J Neurosurg; 2016 Aug; 125(2):393-400. PubMed ID: 26722849
[TBL] [Abstract][Full Text] [Related]
31. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.
Sarmiento JM; Venteicher AS; Patil CG
Cochrane Database Syst Rev; 2015 Jun; 6(6):CD009229. PubMed ID: 26118544
[TBL] [Abstract][Full Text] [Related]
32. Is there a risk of seizures in "preventive" awake surgery for incidental diffuse low-grade gliomas?
Lima GL; Duffau H
J Neurosurg; 2015 Jun; 122(6):1397-405. PubMed ID: 25723301
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.
Nunna RS; Khalid S; Ryoo JS; Sethi A; Byrne RW; Mehta AI
Clin Transl Oncol; 2021 Mar; 23(3):628-637. PubMed ID: 32691365
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
35. Benign Glioma.
Wu PB; Filley AC; Miller ML; Bruce JN
Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
[TBL] [Abstract][Full Text] [Related]
36. Cellular telephones and risk for brain tumors: a population-based, incident case-control study.
Christensen HC; Schüz J; Kosteljanetz M; Poulsen HS; Boice JD; McLaughlin JK; Johansen C
Neurology; 2005 Apr; 64(7):1189-95. PubMed ID: 15824345
[TBL] [Abstract][Full Text] [Related]
37. Differences in Type Composition of Symptom Clusters as Predictors of Quality of Life in Patients with Meningioma and Glioma.
Kim SR; Shin YS; Kim JH; Choi M; Yoo SH
World Neurosurg; 2017 Feb; 98():50-59. PubMed ID: 27794512
[TBL] [Abstract][Full Text] [Related]
38. Perioperative and Postoperative Quality of Life in Patients with Glioma-A Longitudinal Cohort Study.
Drewes C; Sagberg LM; Jakola AS; Solheim O
World Neurosurg; 2018 Sep; 117():e465-e474. PubMed ID: 29920391
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
40. Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.
Cochereau J; Herbet G; Rigau V; Duffau H
J Neurosurg; 2016 Jan; 124(1):141-5. PubMed ID: 26162036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
